Sunflower Pharmaceutical Group Co.,Ltd

Shenzhen Stock Exchange 002737.SZ

Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio for the year ending December 31, 2023: 215.40

Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio is 215.40 for the year ending December 31, 2023, a 91.75% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio for the year ending December 31, 2022 was 112.33, a 26.32% change year over year.
Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio for the year ending December 31, 2021 was 88.92, a -14.90% change year over year.
Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio for the year ending December 31, 2020 was 104.49, a 60.45% change year over year.
Sunflower Pharmaceutical Group Co.,Ltd Interest Coverage Ratio for the year ending December 31, 2019 was 65.12, a -41.87% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shenzhen Stock Exchange: 002737.SZ

Sunflower Pharmaceutical Group Co.,Ltd

CEO	Ms. Yi Guan
IPO Date	Dec. 30, 2014
Location	China
Headquarters	Concentrated Area, Yingbin Road
Employees	5,776
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Sunflower Pharmaceutical Group Co.,Ltd researches, develops, manufactures, and markets Chinese patent medicines in China. The company also produces chemical, biological, and health care medicines. Its products are used in therapeutic areas, such as pediatrics, gynecology, digestive system, respiratory and cold, rheumatism and bone disease, and cardiovascular and cerebrovascular. The company sells its products under the Sunflower and Little Sunflower brands. Sunflower Pharmaceutical Group Co.,Ltd was founded in 2005 and is based in Harbin, China.

Key trends

Past 5 years